BiotechTube
Home/VS3 Medical/Thomas C. Wilder
TC

Thomas C. Wilder

Chief Executive Officer

VS3 Medical

Therapeutic Areas

NeurovascularOtology/Neurology

VS3 Medical Pipeline

DrugIndicationPhase
VS3 Medical Stent SystemSymptomatic Venous Sinus Stenosis (VSS)First-in-Human

Leadership Team at VS3 Medical

MA
Matthew Amans, MD
Founder
MH
Mike Horzewski
Co-Founder, Chief Operating Officer
ML
Mary Lou Mooney
VP, Regulatory, Clinical & Quality Affairs
ND
Nick deBeer
Vice President, Research & Development
View full VS3 Medical profile